Table 2.

Prevalence of infection [n (%)] with β-HPV types and species in the Ludwig-McGill Cohort Study (n = 505)

Type-specific β-HPVPositivity at enrollmentPositivity at 1-year follow-upPositivity at enrollment AND follow-upPositivity at enrollment OR follow-up
HPV55 (0.99)4 (0.79)09 (1.78)
HPV83 (0.59)8 (1.58)011 (2.18)
HPV91 (0.20)1 (0.20)02 (0.40)
HPV122 (0.40)4 (0.79)06 (1.19)
HPV1401 (0.20)01 (0.20)
HPV153 (0.59)003 (0.59)
HPV171 (0.20)1 (0.20)1 (0.20)1 (0.20)
HPV191 (0.20)1 (0.20)02 (0.40)
HPV200000
HPV2121 (4.16)7 (1.39)028 (5.54)
HPV228 (1.58)13 (2.57)1 (0.20)20 (3.96)
HPV2302 (0.40)02 (0.40)
HPV243 (0.59)7 (1.39)010 (1.98)
HPV250000
HPV36010 (1.98)010 (1.98)
HPV370000
HPV3814 (2.77)8 (1.58)022 (4.36)
HPV4702 (0.40)02 (0.40)
HPV491 (0.20)001 (0.20)
HPV750000
HPV763 (0.59)6 (1.19)09 (1.78)
HPV800000
HPV9201 (0.20)01 (0.20)
HPV930000
HPV961 (0.20)2 (0.40)03 (0.59)
HPV980000
HPV990000
HPV1002 (0.40)1 (0.20)03 (0.59)
HPV1040000
HPV1051 (0.20)1 (0.20)02 (0.40)
HPV10702 (0.40)02 (0.40)
HPV1103 (0.59)3 (0.59)06 (1.19)
HPV11110 (1.98)2 (0.40)012 (2.38)
HPV1131 (0.20)001 (0.20)
HPV1150000
HPV1180000
HPV1202 (0.40)1 (0.20)03 (0.59)
HPV12207 (1.39)07 (1.39)
HPV1241 (0.20)001 (0.20)
HPV1430000
HPV1450000
HPV1500000
HPV1511 (0.20)001 (0.20)
β-HPV speciesa
β-133 (6.53)39 (7.72)3 (0.59)69 (13.66)
β-244 (8.71)37 (7.33)5 (0.99)76 (15.05)
β-34 (0.79)6 (1.19)010 (1.98)
β-401 (0.20)01 (0.20)
β-51 (0.20)2 (0.40)03 (0.59)
Any β-HPV75 (14.85)73 (14.46)10 (1.98)138 (27.33)
  • aβ-HPV species: β-1 (HPVs 5, 8, 12, 14, 19, 21, 24, 36, 47, 105, 124); β-2 (HPVs 9, 15, 17, 22, 23, 38, 100, 107, 110, 111, 113, 120, 122, 151); β-3 (HPVs 49, 76); β-4 (HPV92); β-5 (HPV96).